Clinical Trials Research Sacramento

Sacramento, California 95821-2134

0 studies enrolling now · 5 studies all time

What they study most

Diabetic Neuropathy, Painful, Diabetic Peripheral Neuropathy, Hypertension, Primary Prevention of Atherosclerotic Cardiovascular Disease, Resistant Hypertension

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients — Running, not enrolling
• An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. — Completed
• Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy — Completed
• A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy — Completed